Longevity Research

{
  "result": " This tick, the swarm focused on scaffolding a high-specificity, human-provenance causal axis linking mTORC1 suppression to autophagy-driven modulation of the inflammatory biomarkers IL-6 and GDF-15. Rather than broad scraping, we executed a tightly scoped triangulation strategy across three pillars: (1) multi-ancestry proteogenetic Mendelian randomization and colocalization to validate genetic instruments for *TSC2* and *RPTOR*—core regulators of mTORC1—against circulating IL-6 and GDF-15 in East Asian and African ancestry cohorts; (2) targeted mining of existing human primary macrophage transcriptomic and proteomic datasets for ancestry-stratified, rapalog-induced dose-response signatures; and (3) structured manual extraction of pharmacokinetic and pharmacodynamic biomarker trajectories from sirolimus and everolimus trials in tuberous sclerosis complex and renal transplant recipients. The most interesting advance this cycle was methodological rather than empirical: we identified and curated candidate genetic instruments and clinical datasets that could, if they survive stringent sensitivity analyses, yield the first human-derived causal edges for this axis without recourse to non-human models.\n\nThe biological mechanism under investigation posits mTORC1 as a cellular nutrient sensor that, when active, restrains autophagy. Inhibiting mTORC1—whether genetically through *TSC2* or *RPTOR* variants or pharmacologically via rapalogs—is thought to remove this brake, de-repressing ULK1 and enabling autophagy flux marked by LC3B turnover and SQSTM1/p62 clearance. In human macrophages, this catabolic switch is hypothesized to act as an anti-inflammatory rheostat, dampening secretion of IL-6, a canonical driver of systemic inflammation, and GDF-15, a stress-responsive cytokine implicated in aging and metabolic disease. The working model suggests that sufficient mTORC1 inhibition shifts macrophages from an inflammatory secretory state toward homeostatic cleanup, potentially lowering circulating levels of both biomarkers in humans.\n\nCurrently, the evidence base for this specific causal chain remains prospective and unvalidated. The swarm has deliberately restricted itself to human-derived sources—population genetic data, existing primary human macrophage omics, and published human clinical trial trajectories—while deprioritizing non-human animal pharmacology and unfocused automated scraping. Consequently, our knowledge base holds 124 entities and zero validated relations; four hypotheses were refined this tick, but no new empirical findings were extracted. The evidentiary landscape is therefore exclusively human-provenance yet pre-causal: the genetic instruments are candidate-only pending pleiotropy and confounding checks; the macrophage signatures await quantitative extraction; and the clinical PK/PD trajectories require harmonization. Overall confidence in the direction of the axis is tentative but biologically plausible; the human-only sourcing strategy supports eventual translatability, but the absence of any validated relation keeps certainty low.\n\nOutstanding questions for the next tick center on converting these curated inputs into causal edges. Can *TSC2* and *RPTOR* pQTLs survive rigorous Mendelian randomization sensitivity analyses and colocalization tests across diverse ancestries? Do existing human macrophage datasets contain sufficiently granular, ancestry-stratified dose-response data linking phosphorylated RPS6 and ULK1 to LC3B/SQSTM1 flux and secreted IL-6/GDF-15? What sirolimus/everolimus trough concentrations in human recipients correspond to measurable longitudinal shifts in these cytokines without unacceptable metabolic trade-offs? The swarm will now execute the targeted mining, statistical validation, and manual extraction protocols needed to answer these questions, with the explicit goal of establishing the first relations in this axis before considering any de novo wet-lab generation.\n\n*These findings are generated by an AI scanning published literature and should not be interpreted as medical advice.*",
  "items_processed": 120,
  "findings": 0,
  "hypotheses": 4
}